To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.

Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL or lymphoma) is a blood cancer that originates in the white ...

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes Project.

Charities are urging Scots to familiarise themselves with the symptoms of leukaemia, which remains little understood despite being one of the deadliest forms of cancer. Around 10,000 Brits are ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...

At the study’s conclusion, the researchers found that female participants had higher levels of total ghrelin and of the DAG form of ghrelin compared to male participants. Both gender groups ...

A laboratory that will deliver ‘home-grown’ CAR-T cells to improve treatment for blood cancers is to open at Addenbrooke’s Hospital. The Cambridge lab will be one of only a handful in the UK capable ...

Longtime broadcaster Charley Steiner revealed to Los Angeles Times columnist Bill Plaschke that his multiple myeloma blood cancer — which he had not previously disclosed — is in remission.

Video / Jason Oxenham Tim Edmonds is the chief executive at Leukaemia & Blood Cancer New Zealand, a national charity that provides specialist support for blood cancer patients and their families ...